drugset / Trial / NCT01326338

Nitazoxanide for the Treatment of Prolonged Diarrhea in Children

NCT01326338

Phase 3 Completed 100 enrolled Romark Laboratories L.C.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to determine the efficacy of nitazoxanide suspension compared to placebo in treating prolonged diarrhea in children.

Timeline

Start
2005-03
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitazoxanide Other / unclassified 100 mg Oral
Subject Nitazoxanide Other / unclassified 200 mg Oral

Indications